216 related articles for article (PubMed ID: 32823614)
1. E2F8 Induces Cell Proliferation and Invasion through the Epithelial-Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer.
Eoh KJ; Kim HJ; Lee JW; Kim LK; Park SA; Kim HS; Kim YT; Koo PJ
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823614
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SRA mediates cell migration, invasion, and progression of ovarian cancer via NOTCH signaling and epithelial-mesenchymal transition.
Kim LK; Park SA; Yang Y; Kim YT; Heo TH; Kim HJ
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34402503
[TBL] [Abstract][Full Text] [Related]
3. E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer.
Kim LK; Park SA; Eoh KJ; Heo TH; Kim YT; Kim HJ
Int J Biol Sci; 2020; 16(2):320-329. PubMed ID: 31929759
[TBL] [Abstract][Full Text] [Related]
4. LAMA5 promotes cell proliferation and migration in ovarian cancer by activating Notch signaling pathway.
Diao B; Sun C; Yu P; Zhao Z; Yang P
FASEB J; 2023 Sep; 37(9):e23109. PubMed ID: 37527216
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.
Eoh KJ; Paek J; Kim SW; Kim HJ; Lee HY; Lee SK; Kim YT
Oncol Rep; 2017 Dec; 38(6):3481-3488. PubMed ID: 29039612
[TBL] [Abstract][Full Text] [Related]
6. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
8. HOXA‑AS3 induces tumor progression through the epithelial‑mesenchymal transition pathway in epithelial ovarian cancer.
Eoh KJ; Lee DW; Nam EJ; Kim JI; Moon H; Kim SW; Kim YT
Oncol Rep; 2023 Mar; 49(3):. PubMed ID: 36799173
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of E2F8 promotes cell proliferation and tumorigenicity in breast cancer by modulating G1/S phase transition.
Ye L; Guo L; He Z; Wang X; Lin C; Zhang X; Wu S; Bao Y; Yang Q; Song L; Lin H
Oncotarget; 2016 Apr; 7(17):23757-71. PubMed ID: 26992224
[TBL] [Abstract][Full Text] [Related]
10. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
[TBL] [Abstract][Full Text] [Related]
12. P76RBE silencing inhibits ovarian cancer cell proliferation, migration, and invasion via suppressing the integrin β1/NF-κB pathway.
Yan L; He Z; Li W; Liu N; Gao S
Cell Cycle; 2021 Sep; 20(18):1875-1889. PubMed ID: 34382920
[TBL] [Abstract][Full Text] [Related]
13. Targeting UDP-glucose dehydrogenase inhibits ovarian cancer growth and metastasis.
Lin LH; Chou HC; Chang SJ; Liao EC; Tsai YT; Wei YS; Chen HY; Lin MW; Wang YS; Chien YA; Yu XR; Chan HL
J Cell Mol Med; 2020 Oct; 24(20):11883-11902. PubMed ID: 32893977
[TBL] [Abstract][Full Text] [Related]
14. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
[TBL] [Abstract][Full Text] [Related]
16. The mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.
Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Gobeil S; Morin C; Macdonald E; Vanderhyden B; Bachvarov D
Oncotarget; 2016 Mar; 7(12):14125-42. PubMed ID: 26871602
[TBL] [Abstract][Full Text] [Related]
17. TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K / AKT oncogenic signaling.
Liu L; Wu N; Wang Y; Zhang X; Xia B; Tang J; Cai J; Zhao Z; Liao Q; Wang J
J Exp Clin Cancer Res; 2019 Feb; 38(1):106. PubMed ID: 30819230
[TBL] [Abstract][Full Text] [Related]
18. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
[No Abstract] [Full Text] [Related]
19. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
Zeng S; Liu S; Feng J; Gao J; Xue F
Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
[TBL] [Abstract][Full Text] [Related]
20. Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.
Zhou J; Jain S; Azad AK; Xu X; Yu HC; Xu Z; Godbout R; Fu Y
Cell Signal; 2016 Aug; 28(8):838-49. PubMed ID: 27075926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
